Login
Cart
Support
Search
Search
Search
Mark Beasley
Appearances
View Grid
EVALUATION OF THE SAFETY AND EFFICACY OF EFLORNITHINE (DIFLUOROMETHYLORNITHINE, DFMO) IN PATIENTS WITH GASTRIC PREMALIGNANT CONDITIONS IN THE HIGH INCIDENCE AREAS OF LATIN AMERICA
Date
May 21, 2024
BACKGROUND. Gastric adenocarcinoma (GAC) is the third leading global cause of cancer mortality and the leading infection-associated cancer. In the U.S., GAC represents a major cancer disparity, with incidence rates 2-3X in non-white populations…
Presenter
Douglas Morgan
The University of Alabama at Birmingham
Speakers
Ricardo Dominguez
Dalton Norwood
Eleazar Montalvan-Sanchez
Maria Piazuelo
Jessica Hernandez-Marrero
Maria Gonzalez-Pons
Elizabeth Bruckheimer
Mark Beasley
Marcia Cruz-Correa
Keith Wilson